Literature DB >> 11422618

Relationship among gastric motility, autonomic activity, and portal hemodynamics in patients with liver cirrhosis.

H Miyajima1, M Nomura, N Muguruma, T Okahisa, H Shibata, S Okamura, H Honda, I Shimizu, M Harada, K Saito, Y Nakaya, S Ito.   

Abstract

BACKGROUND AND AIMS: We examined the effects of the autonomic nervous function and the volume of portal blood flow to clarify the mechanism of the abnormal gastric motility in patients with liver cirrhosis.
METHODS: Heart rate variability, electrogastrogram (EGG), and volume of portal blood flow were measured before and after a meal in 27 patients with liver cirrhosis (LC group) and in 20 normal subjects (N group). Autonomic nervous function was evaluated by using spectral analysis of heart rate variability. We used the cine phase-contrast (PC) method, using magnetic resonance imaging (MRI) to measure the portal flow, while the peak frequency and spectral power of the EGG were measured at pre- and postprandial change.
RESULTS: The ratio of low frequency power to high frequency power (LF/HF) was significantly higher, and the HF power was significantly lower in the LC group than in the N group both before and after a meal. In both groups, the electrogastrographic peak power ratio before and after a meal showed a positive correlation with the HF ratio, and an inverse correlation with the LF/HF ratio. In addition, portal blood flow volume was significantly decreased in the LC group than in the N group. However, the increased rate of portal blood flow after a meal correlated positively with the increased rate of electrogastrographic peak power. Moreover, gastric motility was positively correlated with esophageal varices and coma scale with the use of multivariate analysis.
CONCLUSIONS: Parasympathetic hypofunction, sympathetic hyperfunction and portal hemodynamics were closely related with gastric motility in cirrhotic patients. In addition, gastric motility was decreased, at least in part, by the ingestion of food in cirrhotic patients because of abnormalities in autonomic functions and portal blood flow following a meal.

Entities:  

Mesh:

Year:  2001        PMID: 11422618     DOI: 10.1046/j.1440-1746.2001.02493.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

Review 1.  Dose adjustment in patients with liver disease.

Authors:  Fabiola Delcò; Lydia Tchambaz; Raymond Schlienger; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes.

Authors:  David S Goldstein; Oladi Bentho; Mee-Yeong Park; Yehonatan Sharabi
Journal:  Exp Physiol       Date:  2011-09-02       Impact factor: 2.969

3.  Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations.

Authors:  Carmen C Franz; Carole Hildbrand; Christa Born; Sabin Egger; Alexandra E Rätz Bravo; Stephan Krähenbühl
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

4.  Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy.

Authors:  Ali R Mani; Sara Montagnese; Clive D Jackson; Christopher W Jenkins; Ian M Head; Robert C Stephens; Kevin P Moore; Marsha Y Morgan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-20       Impact factor: 4.052

Review 5.  Changes of Intestinal Functions in Liver Cirrhosis.

Authors:  Hiroshi Fukui; Reiner Wiest
Journal:  Inflamm Intest Dis       Date:  2016-03-08

6.  Association of heart rate variability, blood pressure variability, and baroreflex sensitivity with gastric motility at rest and during cold pressor test.

Authors:  Kiran Prakash; Amandeep Thakur; Anita S Malhotra
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

7.  A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls.

Authors:  Anne B Taegtmeyer; Manuel Haschke; Lydia Tchambaz; Mirabel Buylaert; Martin Tschöpl; Ulrich Beuers; Jürgen Drewe; Stephan Krähenbühl
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

Review 8.  Gastrointestinal Motility Disorders and Their Clinical Implications in Cirrhosis.

Authors:  Eleni Theocharidou; Ameet Dhar; David Patch
Journal:  Gastroenterol Res Pract       Date:  2017-05-11       Impact factor: 2.260

9.  Gastric food retention at endoscopy is associated with severity of liver cirrhosis.

Authors:  David B Snell; Shirley Cohen-Mekelburg; Russell Weg; Gaurav Ghosh; Adam P Buckholz; Amit Mehta; Xiaoyue Ma; Paul J Christos; Arun B Jesudian
Journal:  World J Hepatol       Date:  2019-11-27

Review 10.  Spectrum of esophageal motility disorders in patients with liver cirrhosis.

Authors:  Mohamed Khalaf; Donald Castell; Puja Sukhwani Elias
Journal:  World J Hepatol       Date:  2020-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.